FDA Issues Final Rule for Over-the-Counter Hearing Aids By Brian Park, PharmD Publish Date August 16, 2022
Olaparib + Abiraterone Gets Priority Review for Castration-Resistant Prostate Cancer By Brian Park, PharmD Publish Date August 16, 2022
FDA to Review Polatuzumab Vedotin Combo Tx for Previously Untreated DLBCL By Brian Park, PharmD Publish Date August 16, 2022
Diuretic Use Varies Widely in US Hemodialysis Practice By Natasha Persaud Publish Date August 16, 2022
Sacituzumab Govitecan sBLA submitted for HR+/HER2- Metastatic Breast Cancer By Brian Park, PharmD Publish Date August 15, 2022
Novavax Submits EUA Request for COVID-19 Vaccine Booster By Brian Park, PharmD Publish Date August 15, 2022
FDA: Repeat At-Home COVID-19 Antigen Tests to Reduce Risk of Missed Infection By Brian Park, PharmD Publish Date August 12, 2022
Enhertu Gets Accelerated Approval for HER2-Mutant Metastatic NSCLC By Brian Park, PharmD Publish Date August 12, 2022
Xofluza Approved to Treat, Prevent Influenza in Pediatric Patients By Brian Park, PharmD Publish Date August 12, 2022
